NCT02946710View on ClinicalTrials.gov

P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

December 31, 2017

Conditions
Alzheimer Disease
Interventions
BIOLOGICAL

cerebrospinal fluid

Biological analysis on cerebrospinal fluid

Trial Locations (1)

Unknown

University Hospital of Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02946710 - P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid | Biotech Hunter | Biotech Hunter